Biohaven Pharma (BHVN) PT Lowered to $18 at Morgan Stanley
Morgan Stanley analyst Terence Flynn ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
